Australia may be the first country to eliminate cervical cancer, but the inequality remains.

Published Date: 08 Mar 2023

Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.

Read Full News

Latest News

Democrats Press RFK Jr. on an Ethics Agreement Change Involving Law Firm Fees

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

Two Procedures May Yield Similar Symptom Relief for Uterine Fibroids

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

Maternal Tdap Blunts Preschoolers' Pertussis Shot Response, but Booster Revives Them

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

FDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

Todays Updates

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

Frontotemporal Dementia Diagnosis, Head Impacts, and Emerging Treatment Approaches Louie Pasculli, Carme Tartaglia, MD

Carmela Tartaglia, MD, FRCPC, discusses the challenges of diagnosing frontotemporal dementia, the evolving role of biomarkers, and emerging approaches to disease modification.

NeurologyLive® Friday 5 — October 9, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 9, 2026.

Personalizing IgA Nephropathy Care Conversations, With Gaia Coppock, MD Gaia Coppock, MD

Why patients with IgA nephropathy want to understand their disease, not just follow instructions.

ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Phase 3 ABTECT data show ~51% clinical remission and ≥40% endoscopic remission with obefazimod through week 44.

Where Could Obefazimod Fit in UC Treatment, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Obefazimod could work as first, second, or third line therapy in ulcerative colitis ahead of a planned FDA submission this year.

Tezepelumab's TSLP Blockade May Address Refractory EoE Gap Arjan Bredenoord, MD

Arjan Bredenoord, MD, details how tezepelumab's selective TSLP inhibition sustained EoE remission through week 52 of the CROSSING trial.

Todays Updates

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

Frontotemporal Dementia Diagnosis, Head Impacts, and Emerging Treatment Approaches Louie Pasculli, Carme Tartaglia, MD

Carmela Tartaglia, MD, FRCPC, discusses the challenges of diagnosing frontotemporal dementia, the evolving role of biomarkers, and emerging approaches to disease modification.

NeurologyLive® Friday 5 — October 9, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 9, 2026.

Personalizing IgA Nephropathy Care Conversations, With Gaia Coppock, MD Gaia Coppock, MD

Why patients with IgA nephropathy want to understand their disease, not just follow instructions.

ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Phase 3 ABTECT data show ~51% clinical remission and ≥40% endoscopic remission with obefazimod through week 44.

Where Could Obefazimod Fit in UC Treatment, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Obefazimod could work as first, second, or third line therapy in ulcerative colitis ahead of a planned FDA submission this year.

Tezepelumab's TSLP Blockade May Address Refractory EoE Gap Arjan Bredenoord, MD

Arjan Bredenoord, MD, details how tezepelumab's selective TSLP inhibition sustained EoE remission through week 52 of the CROSSING trial.

Latest News

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

News All Time

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV

Combo could offer an alternative for those who can't take existing single-tablet regimens

Her Breast MRI Was Approved, but That Didn't Mean Her Insurance Would Pay

High-risk patients face steep, surprise bills for preventive breast MRIs

Lionel Richie Hospitalized; CDC Challenges Measles Toll; Vitamin K Refusals Rise

Health news and commentary gathered by MedPage Today staff

Nurse Who Saved Baby in Pakistan Hospital Fire Wishes She Could Have Saved the Rest

"I acted as a mother," she said

Gloria Steinem on Women's Rights, Abortion Politics, and Being Called the B-Word

And what she thought about Roe v. Wade being overturned

Judge Declares Mistrial in Lindsay Clancy Case

Defense attorney said she was suffering from postpartum psychosis when she strangled her kids

Judge Sends Deadlocked Lindsay Clancy Jurors Home

Foreperson said a single juror won't follow the court's instructions about reasonable doubt

One of the Lindsay Clancy Trial's Most Instructive Moments for Physicians

The author of a medical record doesn't always retain ownership of its meaning

Breast Cancer Drug Wins Approval Despite Rejection by Agency Advisors

Oral SERD camizestrant lands indication for use in novel first-line treatment strategy

Trump Pardon Sought for Clancy; Sen. Marshall's Medical Debt Suits; Lasker Winners

Health news and commentary gathered by MedPage Today staff

An Appeals Court Is Considering a Push to Restrict Most Common Abortion Method

The political situation is tricky for President Trump

Ectopic Pregnancy Deaths Have Nearly Doubled. It's Worse in Abortion-Ban States.

"This is a potentially profound consequence of the regulation," said one abortion policy expert

Residency Software Developer Sues Doctor Who Helped Launch a Competing Product

AAMC-partnered Thalamus goes after key players in ResidencyCAS

Bipartisan Campaign Pledges $100M to Cut U.S. Maternal Mortality Rate in Half

Problem is "eminently solvable," says president of Healthy Moms, Healthy Babies America

Recommended News For You

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

The hidden costs of cancer for young survivors are derailing their financial futures

How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Belzutifan Plus Pembro Approved for Adjuvant RCC

Recommended Articles For You

Case-Based Learning on Clonal Hematopoiesis With Unexpected Clinical Progression 

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025 

Progressive Frameworks in Hematology Across Clinical Settings 

Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

2.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

3.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

4.

Urinary tract cancer prediction models with high sensitivity and specificity

5.

Mapping lifelong chronic health risks for childhood cancer survivors

1.

Modern Updates in Hematology in the Digital Era

2.

Mechanisms of Tumor Cell Plasticity During Metastatic Spread

3.

Oral Treatment Strategies in Psoriasis & Melasma: Where Are We Heading?

4.

The Science Behind Thrombolytic Drugs and Their Benefits 

5.

Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder

1.

International Conference on Oncology, Cardiology and Critical Care Policy

2.

International Conference on Innovations in Critical Care for Oncology and Cardiology

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Cancer Nursing and Hematology Support

1.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot